Beijing Tiantan Biological Products Co., Ltd. (600161.SS) SHH

Currency In CNY

AD

Valuation

Market Cap32.31B
Enterprise Value30.51B
P/E Ratio24.81
PEG Ratio-0.84
Price/Sales Ratio4.1
Price/Book Ratio2.06
Enterprise/Revenue3.8
Enterprise/EBITDA11.65

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.16
Operating Margin0.27
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue6.14B
Revenue/Share3.01
Gross Profit2.58B
EBITDA2.29B
Net Income1.09B
Diluted EPS0.55

Balance Sheet

Total Cash1.89B
Total Cash/Share0.96
Total Debt91.8M
Total Debt/Equity0.01
Current Ratio8.82
Book Value Per Share7.84

Price History

52-Week Change-35.24
52-Week High22.08
52-Week Low11.78
Moving Average 50 Days13.83
Moving Average 200 Days16.4

Statistics

Average Volume10.55M
Shares Outstanding1.98B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield2.02
Payout Ratio0.71
Last Split Factor6:5
Last Split DateJune 20, 2024
AD